Expert Opinion on Therapeutic Patents, Volume 16, Issue 12 (2006)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Expert Opinion on Therapeutic Patents, Volume 16, Issue 12 (2006)

See all volumes and issues
Vol 34, 2024 Vol 33, 2023 Vol 32, 2022 Vol 31, 2021 Vol 30, 2020 Vol 29, 2019 Vol 28, 2018 Vol 27, 2017 Vol 26, 2016 Vol 25, 2015 Vol 24, 2014 Vol 23, 2013 Vol 22, 2012 Vol 21, 2011 Vol 20, 2010 Vol 19, 2009 Vol 18, 2008 Vol 17, 2007 Volume 16, 2006 Vol 15, 2005 Vol 14, 2004 Vol 13, 2003 Vol 12, 2002 Vol 11, 2001 Vol 10, 2000 Vol 9, 1999 Vol 8, 1998 Vol 7, 1997 Vol 6, 1996 Vol 5, 1995 Vol 4, 1994 Vol 3, 1993 Vol 2, 1992 Vol 1, 1991
Download citations Download PDFs Download issue

Editorial

Article
Clopidogrel bisulfate (Plavix®, Sanofi and Bristol-Myers Squibb): another billion dollar drug under attack by the generics
Komal Shah Bhukhanwala & Rca Godbole
Pages: 1609-1611
Published online: 22 Nov 2006
AbstractforClopidogrel bisulfate (Plavix®, Sanofi and Bristol-Myers Squibb): another billion dollar drug under attack by the generics | Full Text | References | PDF (82.5 KB)
  • 55 Views
  • 1 CrossRef citations
  • 0Altmetric
Article
Existing dopaminergic therapies for Parkinson’s disease
Aloke K Dutta PhD & Weidong Le MD, PhD
Pages: 1613-1625
Published online: 22 Nov 2006
AbstractforExisting dopaminergic therapies for Parkinson’s disease | Full Text | References | PDF (196.7 KB)
  • 73 Views
  • 13 CrossRef citations
  • 0Altmetric

Review

Article
Carbonic anhydrase inhibitors and activators and their use in therapy
Andrea Scozzafava, Antonio Mastrolorenzo & Claudiu T Supuran
Pages: 1627-1664
Published online: 22 Nov 2006
AbstractforCarbonic anhydrase inhibitors and activators and their use in therapy | Full Text | References | PDF (3.1 MB)
  • 326 Views
  • 145 CrossRef citations
  • 0Altmetric
Article
Anticancer activity of artemisinin-derived trioxanes
Gary H Posner, John D’Angelo, Paul M O’Neill & Amy Mercer
Pages: 1665-1672
Published online: 22 Nov 2006
AbstractforAnticancer activity of artemisinin-derived trioxanes | Full Text | References | PDF (143.3 KB)
  • 93 Views
  • 38 CrossRef citations
  • 0Altmetric
Article
An update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis
D Jonathan Bennett, Lindsay D Brown, Andrew J Cooke & Andrew S Edwards
Pages: 1673-1699
Published online: 22 Nov 2006
AbstractforAn update on non-steroidal liver X receptor agonists and their potential use in the treatment of atherosclerosis | Full Text | References | PDF (332.5 KB)
  • 100 Views
  • 10 CrossRef citations
  • 0Altmetric
Article
Neuropeptide Y receptors as targets of obesity treatment
Akane Ishihara PhD, Minoru Moriya PhD, Douglas J MacNeil PhD, Takehiro Fukami PhD & Akio Kanatani PhD
Pages: 1701-1712
Published online: 22 Nov 2006
AbstractforNeuropeptide Y receptors as targets of obesity treatment | Full Text | References | PDF (178.5 KB)
  • 78 Views
  • 9 CrossRef citations
  • 0Altmetric
Article
Existing and potential therapeutic approaches targeting peroxisome proliferator-activated receptors in the management of Type 2 diabetes
Dr Adam Stefanski & Liliana Majkowska
Pages: 1713-1733
Published online: 22 Nov 2006
AbstractforExisting and potential therapeutic approaches targeting peroxisome proliferator-activated receptors in the management of Type 2 diabetes | Full Text | References | PDF (260.3 KB)
  • 49 Views
  • 3 CrossRef citations
  • 0Altmetric

Annotated Patent Selections

Article
Annotated Patent Selections
Pages: 1735-1751
Published online: 22 Nov 2006
First Page PreviewforAnnotated Patent Selections | Full Text | PDF (247.1 KB)
  • 59 Views
  • 0 CrossRef citations
  • 0Altmetric

Patent Evaluation

Article
Long-acting β2 agonists: Pfizer’s development candidate?
WO2006051373 and WO2006051375
Peter Norman
Pages: 1753-1757
Published online: 22 Nov 2006
AbstractforLong-acting β2 agonists: Pfizer’s development candidate? | Full Text | References | PDF (109 KB)
  • 24 Views
  • 1 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

An insight into the last 5-year patents on Porphyromonas gingivalis and Streptococcus mutans, the pivotal pathogens in the oral cavity
Bianca Laura Bernardoni et al.
Review Article | Published online: 20 May 2024
Synthetic lethality: targeting the SMARCA2 bromodomain for degradation in SMARCA4-deficient tumors – a review of patent literature from 2019–June 2023
Esther C. Y. Lee et al.
Review Article | Published online: 20 May 2024
Anticancer drugs: where are we now?
Giuseppina De Simone et al.
Editorial | Published online: 15 May 2024
Free Access
Recent trends and challenges to overcome Pseudomonas aeruginosa infections
Alessandra Ammazzalorso et al.
Review Article | Published online: 3 May 2024
View all latest articles